Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: PMV Pharmaceuticals Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Acrivon Therapeutics Inc. June 17, 202693.7%
-
PMV Pharmaceuticals Inc. June 5, 202541.6%
-
Acrivon Therapeutics Inc. June 22, 202399.5%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 18, 2026 | Acrivon Therapeutics Inc. | Grant or award | +9,366 | — | — |
Questions about Charles M. Baum
What boards is Charles M. Baum on?
Charles M. Baum sits on the boards of Acrivon Therapeutics Inc. and PMV Pharmaceuticals Inc.
How long has Charles M. Baum served on boards?
Our records show at least 7 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.